BIAXIN- clarithromycin tablet, film coated
BIAXIN- clarithromycin tablet, film coated, extended release
BIAXIN- clarithromycin USA - engelsk - NLM (National Library of Medicine)

biaxin- clarithromycin tablet, film coated biaxin- clarithromycin tablet, film coated, extended release biaxin- clarithromycin

physicians total care, inc. - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin 250 mg - biaxin filmtab (clarithromycin tablets, usp) and biaxin granules (clarithromycin for oral suspension, usp) are indicated for the treatment of mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions as listed below: pharyngitis/tonsillitis due to streptococcus pyogenes (the usual drug of choice in the treatment and prevention of streptococcal infections and the prophylaxis of rheumatic fever is penicillin administered by either the intramuscular or the oral route. clarithromycin is generally effective in the eradication of s. pyogenes from the nasopharynx; however, data establishing the efficacy of clarithromycin in the subsequent prevention of rheumatic fever are not available at present). acute maxillary sinusitis due to haemophilus influenzae , moraxella catarrhalis , or streptococcus pneumoniae . acute bacterial exacerbation of chronic bronchitis due to haemophilus influenzae , haemophilus parainfluenzae , moraxella catarrhalis , or streptococcus pn

Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

clarithromycin 500 mg powder for concentrate for solution for infusion

mercury pharmaceuticals ltd - clarithromycin; clarithromycin - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; clarithromycin

CLARITHROMYCINE ACCORD 250 mg, comprimé pelliculé Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

clarithromycine accord 250 mg, comprimé pelliculé

accord healthcare france sas - clarithromycine 250 mg - comprimé - 250 mg - pour un comprimé > clarithromycine 250 mg - macrolides - clarithromycine accord 250 mg, comprimé pelliculé appartient à un groupe d’antibiotique de la famille des macrolides. les antibiotiques arrêtent la croissance des bactéries responsables de l’infection.clarithromycine accord 250 mg, comprimé pelliculé est utilisé dans le traitement des infections bactériennes suivantes, qui ont été préalablement diagnostiquées par votre médecin : infections thoraciques telles que bronchites et pneumonies communautaires, infections de la gorge et des sinus, infections cutanées et des tissus (impétigo, érysipèles, érythrasma), en association, en vue de l’éradication de helicobacter pylori en cas de maladie ulcéreuse gastro-duodénale (cette indication est restreinte à l’adulte seulement).clarithromycine accord est indiqué chez les adultes et les adolescents de plus de 12 ans..

CLARITHROMYCIN- clarithromycin tablet, film coated, extended release USA - engelsk - NLM (National Library of Medicine)

clarithromycin- clarithromycin tablet, film coated, extended release

preferred pharmaceuticals inc. - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin extended-release tablets are indicated in adults for the treatment of mild to moderate infections caused by susceptible isolates due to haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis, or streptococcus pneumoniae [see indications and usage (1.9)] . clarithromycin extended-release tablets (in adults) are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to haemophilus influenzae, moraxella catarrhalis, or streptococcus pneumoniae [see indications and usage (1.9)] . clarithromycin extended-release tablets are indicated [see indications and usage (1.9)] for the treatment of mild to moderate infections caused by susceptible isolates due to: clarithromycin extended-release tablets are indicated only for acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, and community-acquired pneumonia in adults. the efficacy and safety of clarithromycin extended-release tablets in treating other infections for which

PMS-CLARITHROMYCIN Comprimé Canada - fransk - Health Canada

pms-clarithromycin comprimé

pharmascience inc - clarithromycine - comprimé - 250mg - clarithromycine 250mg - other macrolides

PMS-CLARITHROMYCIN Comprimé Canada - fransk - Health Canada

pms-clarithromycin comprimé

pharmascience inc - clarithromycine - comprimé - 500mg - clarithromycine 500mg - other macrolides

MYLAN-CLARITHROMYCIN Comprimé Canada - fransk - Health Canada

mylan-clarithromycin comprimé

mylan pharmaceuticals ulc - clarithromycine - comprimé - 250mg - clarithromycine 250mg - other macrolides

MYLAN-CLARITHROMYCIN Comprimé Canada - fransk - Health Canada

mylan-clarithromycin comprimé

mylan pharmaceuticals ulc - clarithromycine - comprimé - 500mg - clarithromycine 500mg - other macrolides

Clarithromycine Uno EG 500 mg compr. lib. prol. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

clarithromycine uno eg 500 mg compr. lib. prol.

eg sa-nv - citrate de clarithromycine 638,8 mg - eq. clarithromycine 500 mg - comprimé à libération prolongée - 500 mg - citrate de clarithromycine 638.8 mg - clarithromycin